Omnichannel marketing is a huge buzzword in pharma these days. As a late adopter ...
The world is abuzz about how generative artificial intelligence (AI), such as OpenAI’s ChatGPT, ...
Nothing is more humbling for a marketer than walking through the convention floor of ...
Over 300 drugs in the U.S. are in limited supply or unavailable, marking the worst ...
The healthcare industry is coming to terms with the longstanding practice of clinical trials ...
Access to medicines have persisting and systemic differences across the globe and within countries. ...
It’s more challenging than ever to be a pharma marketer. Rapid changes in the ...
The healthcare industry has been transformed by the COVID-19 pandemic, and the diagnostic market ...
Let’s just say it: Everyone is biased. Yes, even in healthcare marketing. As two ...
Funding and access are not new topics of conversation in the rare disease space. ...
In rare disease, every challenge is magnified, beginning with the first. Simply put, identifying ...
While all patient communities and advocacy groups offer patients, their families, and their caregivers ...
Across Europe, pharmaceutical reps are struggling to get access to healthcare professionals. This problem ...